XML 63 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Segment and Geographic Information (Tables)
6 Months Ended
Oct. 30, 2020
Segment Reporting [Abstract]  
Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated
The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:
Segment Operating Profit
 Three months endedSix months ended
(in millions)October 30, 2020October 25, 2019October 30, 2020October 25, 2019
Cardiac and Vascular Group$992 $1,128 $1,751 $2,183 
Minimally Invasive Therapies Group775 823 1,230 1,593 
Restorative Therapies Group805 840 1,327 1,633 
Diabetes Group132 148 235 297 
Segment operating profit2,704 2,939 4,543 5,706 
Interest expense(470)(165)(641)(774)
Other non-operating income, net65 108 147 209 
Amortization of intangible assets(443)(441)(884)(881)
Corporate(460)(350)(825)(657)
Centralized distribution costs(542)(424)(940)(768)
Restructuring and associated costs(179)(94)(307)(218)
Acquisition-related items(37)(27)68 (46)
Certain litigation charges, net(84)(121)(168)
IPR&D charges(10)— (19)— 
Exit of businesses— (41)— (41)
Debt tender premium and other charges— — — 
Medical device regulations(19)(10)(37)(18)
Contribution to Medtronic Foundation— (80)— (80)
Income before income taxes$525 $1,294 $1,109 $2,271 
Net Sales to External Customers by Geography The following table presents net sales for the three and six months ended October 30, 2020 and October 25, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries:    
 Three months endedSix months ended
(in millions)October 30, 2020October 25, 2019October 30, 2020October 25, 2019
Ireland$24 $23 $49 $43 
United States 4,054 4,129 7,405 8,046 
Rest of world3,569 3,554 6,700 7,110 
Total other countries, excluding Ireland7,623 7,683 14,105 15,156 
Total$7,647 $7,706 $14,154 $15,199